Boiling Points: Hot documents in antitrust merger cases
How management or a deal team describes its deal can significantly impact merger reviews and the likelihood of obtaining antitrust approval. Hot documents often lead to deals being delayed and even blocked.
Through the Boiling Points collection and program, our antitrust lawyers offer counsel and business teams practical guidance to help prevent costly deal delays or challenges that can stem from hot documents.
Cartel Regulation 2022
Published by Lexology: Getting the Deal Through, the guide provides an in-depth, practical review by jurisdiction of relevant statutes, enforcement actions, immunity and leniency options, and contested proceedings and penalties, in addition to highlights on recent developments. The guide also addresses strategies for mitigating risks and limiting potential fines.
Dechert antitrust co-chair Steven Bizar and associate Julia Chapman have authored the guide’s chapter on the United States jurisdiction— and antitrust partner Mélanie Thill-Tayara and national partner Marion Provost have authored the European chapter.
Review the U.S. chapter, the EU chapter or the complete guide today.
Pharmaceutical Antitrust 2021 Guide
Antitrust/competition partners Mike Cowie, George Gordon and Mélanie Thill-Tayara are the editors of Pharmaceutical Antitrust. The insightful and easy-to-use reference guide published by Lexology: Getting the Deal Through, provides comparative transatlantic analysis and insights into this industry. Dechert's antitrust lawyers also authored the guide's European Union, German, United Kingdom and United States chapters.
Review the full guide.
Vertical Restraints Tool
Antitrust scrutiny of vertical restraints has evolved significantly over time relative to other areas of U.S. and EU antitrust law. To help provide you with a high-level view of recent activity around vertical restraints, our antitrust lawyers have authored case summaries and analysis both in the U.S. and EU in Global Competition Review’s “Vertical Restraints Tool.”
View case analysis for the United States or Europe.